Changes in Ownership

CRISPR Therapeutics AG Filed 2020-12-09 Acc 0000899243-20-033215

Director sold 171,004 shares at an average $154.53 ($26,424,505)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−4,809	$144.39	$694,384	513,381	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−2,762	$145.43	$401,676	510,619	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−4,203	$146.57	$616,017	506,416	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−24,077	$147.40	$3,548,969	482,339	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−12,703	$148.45	$1,885,729	469,636	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−9,416	$149.41	$1,406,835	460,220	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−7,067	$150.57	$1,064,087	453,153	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−600	$151.32	$90,790	452,553	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−10,098	$153.44	$1,549,433	442,455	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−4,300	$154.41	$663,943	438,155	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−12,123	$155.36	$1,883,422	426,032	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−4,457	$156.53	$697,655	421,575	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−8,582	$157.54	$1,351,994	412,993	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−15,260	$158.41	$2,417,271	397,733	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−8,453	$159.48	$1,348,077	389,280	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−9,397	$160.50	$1,508,195	379,883	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−17,627	$161.57	$2,848,028	362,256	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−14,270	$162.40	$2,317,497	347,986	I
Bolzon Bradley J PhD Director	2020-12-07	Sale	−800	$163.13	$130,505	347,186	I
Open-market sales · 171,004 sh · avg $154.53 · $26,424,505